Search research articles
Contact Us
Filters
Showing results (21-30 of 83) with videos related to
Page
of 9
Sort By:
The Biochemical Journal
|
September 14, 2013
Differential contribution of isoaspartate post-translational modifications to the fibrillization and toxic properties of amyloid β and the Asn23 Iowa mutation
Silvia Fossati, Krysti Todd, Krystal Sotolongo, et al.
Hirosaki Igaku = Hirosaki Medical Journal
|
November 2, 2010
CEREBRAL AMYLOID ANGIOPATHY AND ALZHEIMER'S DISEASE
Jorge Ghiso, Yasushi Tomidokoro, Tamas Revesz, et al.
Drug News & Perspectives
|
April 5, 2003
Vascular Amyloidosis in Neurodegenerative Conditions
Etsuro Matsubara, Mikio Shoji, Koji Abe, et al.
Molecular Medicine (Cambridge, Mass.)
|
October 24, 2002
Human cerebrospinal fluid apolipoprotein E isoforms are apparently inefficient at complexing with synthetic Alzheimer's amyloid-[beta] peptide (A[beta] 1-40 ) in vitro
Zhongmin Zhou, Norman Relkin, Jorge Ghiso, et al.
Cellular and Molecular Life Sciences : CMLS
|
November 10, 2009
Cerebral amyloidosis: amyloid subunits, mutants and phenotypes
A Rostagno, J L Holton, T Lashley, et al.
Aging Cell
|
November 6, 2020
Alzheimer's amyloid β heterogeneous species differentially affect brain endothelial cell viability, blood-brain barrier integrity, and angiogenesis
Rebecca Parodi-Rullán, Jorge Ghiso, Erwin Cabrera, et al.
Antioxidants (Basel, Switzerland)
|
November 27, 2025
Antioxidants Trolox and Methazolamide Protect Microvascular Endothelial Cells from Oxidative Damage Induced by Sporadic and Familial Forms of Oligomeric Amyloid-β
Maria Luisa Valle, Bitseat Getaneh, Christopher William, et al.
Current Alzheimer Research
|
May 25, 2013
BRI2 interacts with BACE1 and regulates its cellular levels by promoting its degradation and reducing its mRNA levels
Maria Tsachaki, Angeliki Fotinopoulou, Nefeli Slavi, et al.
British Journal of Haematology
|
October 3, 2002
Tumoral non-amyloidotic monoclonal immunoglobulin light chain deposits ('aggregoma'): presenting feature of B-cell dyscrasia in three cases with immunohistochemical and biochemical analyses
Agueda Rostagno, Glauco Frizzera, Lourdes Ylagan, et al.
Investigative Ophthalmology & Visual Science
|
February 20, 2014
Clusterin and complement activation in exfoliation glaucoma
Ivo Doudevski, Agueda Rostagno, Mary Cowman, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 83) with videos related to
Sort By:
Page
of 9
The Biochemical Journal
|
September 14, 2013
Differential contribution of isoaspartate post-translational modifications to the fibrillization and toxic properties of amyloid β and the Asn23 Iowa mutation
Silvia Fossati, Krysti Todd, Krystal Sotolongo, et al.
Hirosaki Igaku = Hirosaki Medical Journal
|
November 2, 2010
CEREBRAL AMYLOID ANGIOPATHY AND ALZHEIMER'S DISEASE
Jorge Ghiso, Yasushi Tomidokoro, Tamas Revesz, et al.
Drug News & Perspectives
|
April 5, 2003
Vascular Amyloidosis in Neurodegenerative Conditions
Etsuro Matsubara, Mikio Shoji, Koji Abe, et al.
Molecular Medicine (Cambridge, Mass.)
|
October 24, 2002
Human cerebrospinal fluid apolipoprotein E isoforms are apparently inefficient at complexing with synthetic Alzheimer's amyloid-[beta] peptide (A[beta] 1-40 ) in vitro
Zhongmin Zhou, Norman Relkin, Jorge Ghiso, et al.
Cellular and Molecular Life Sciences : CMLS
|
November 10, 2009
Cerebral amyloidosis: amyloid subunits, mutants and phenotypes
A Rostagno, J L Holton, T Lashley, et al.
Aging Cell
|
November 6, 2020
Alzheimer's amyloid β heterogeneous species differentially affect brain endothelial cell viability, blood-brain barrier integrity, and angiogenesis
Rebecca Parodi-Rullán, Jorge Ghiso, Erwin Cabrera, et al.
Antioxidants (Basel, Switzerland)
|
November 27, 2025
Antioxidants Trolox and Methazolamide Protect Microvascular Endothelial Cells from Oxidative Damage Induced by Sporadic and Familial Forms of Oligomeric Amyloid-β
Maria Luisa Valle, Bitseat Getaneh, Christopher William, et al.
Current Alzheimer Research
|
May 25, 2013
BRI2 interacts with BACE1 and regulates its cellular levels by promoting its degradation and reducing its mRNA levels
Maria Tsachaki, Angeliki Fotinopoulou, Nefeli Slavi, et al.
British Journal of Haematology
|
October 3, 2002
Tumoral non-amyloidotic monoclonal immunoglobulin light chain deposits ('aggregoma'): presenting feature of B-cell dyscrasia in three cases with immunohistochemical and biochemical analyses
Agueda Rostagno, Glauco Frizzera, Lourdes Ylagan, et al.
Investigative Ophthalmology & Visual Science
|
February 20, 2014
Clusterin and complement activation in exfoliation glaucoma
Ivo Doudevski, Agueda Rostagno, Mary Cowman, et al.
Page
of 9